Skip to content

Prohibited Substance

Neostigmine bromide [INN:BAN:JAN]

CAS 114-80-7 Updated
4

Safety score · 0–100

Avoid

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

An acetylcholinesterase-inhibitor drug used for myasthenia gravis. Banned in EU cosmetics under Annex II — cholinergic drugs cause systemic toxicity and have no cosmetic application.

Skin benefits

  • Not a cosmetic ingredient

Known concerns

  • EU Annex II prohibited
  • Acetylcholinesterase inhibitor
  • Pharmaceutical-only
  • Acute systemic toxicity if absorbed

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related prohibited substances

4
DL-aminomethyl-3-hydroxybenzyl alcohol hydrochloride
Prohibited Substance
 4
Methyl acrylamidomethoxyacetate, if the content of acrylamide >= 0.1%
Prohibited Substance
 4
Tar, coal
Prohibited Substance
 4
Trioxsalen [USAN]
Prohibited Substance
 4
benzylmorphine
Prohibited Substance
 5
Dryvax (Smallpox Vaccine)
Prohibited Substance
 5
Methylprednisolone Sodium Succinate [USAN:JAN]
Prohibited Substance
 3
Nickel oxide
Prohibited Substance

Check your shelf

Find Neostigmine bromide [INN:BAN:JAN] in your products.

Scan any cosmetic product with LuxSense to see if it contains Neostigmine bromide [INN:BAN:JAN] and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.